Cheena Ramrakhiani, MD
Cardiovascular Disease (Cardiology) · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 14
- 2 carriers
- Offices
- 2
Offices
2 locations · Stanford Health Care · Sutter Bay Medical Foundation
Hospitals listed: El Camino Health · Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
14 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Ramrakhiani’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
14 of 14 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Sutter Advantage +More (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A87538 · Current
Licensed to practise in California · since 2004 · expires 2028-06-30 · University of Rajasthan, S. M. S. Medical College.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$669,889
Medicare paid this office $669,889 for 3,451 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Analysis of data from ct study of heart blood vessels to assess severity of heart artery disease, with interpretation and report | 139 | $139,135 | $1,001 |
| Return visit (30+ min) | 567 | $105,835 | $111 |
| Ct scan of blood vessels and grafts of heart with contrast | 361 | $105,487 | $292 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 418 | $81,057 | $192 |
| Long return visit (40+ min) | 343 | $76,358 | $162 |
See all 25 services
| Analysis of data from ct study of heart blood vessels to assess severity of heart artery disease, with interpretation and report | 139 | $139,135 | $1,001 |
| Return visit (30+ min) | 567 | $105,835 | $111 |
| Ct scan of blood vessels and grafts of heart with contrast | 361 | $105,487 | $292 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 418 | $81,057 | $192 |
| Long return visit (40+ min) | 343 | $76,358 | $162 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 164 | $37,847 | $231 |
| New patient visit (60+ min) | 95 | $18,091 | $190 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 69 | $15,879 | $104 |
| Ct scan of heart with evaluation of blood vessel calcium | 147 | $13,640 | $93 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 591 | $12,757 | $15 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 946 | $10,968 | $7 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 70 | $10,855 | $151 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 397 | $9,325 | $23 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 637 | $8,869 | $13 |
| Heart rhythm recording of continous external ekg over 8-15 days | 390 | $5,224 | $13 |
| Ct scan of heart structure with contrast | 20 | $4,902 | $245 |
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 381 | $4,099 | $0 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 54 | $1,092 | $20 |
| External shock to heart to regulate heart beat | 11 | $1,078 | $98 |
| Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | 53 | $679 | $13 |
| Ambulatory blood pressure monitoring, 1 day or longer, with recording, scanning analysis, interpretation, and report | 13 | $591 | $45 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 11 | $97 | $7 |
| Blood test, clotting time | 18 | $92 | $4 |
| Injection, dobutamine hydrochloride, per 250 mg | 12 | $81 | None |
| Unclassified drugs | 19 | $52 | None |
Who their Medicare patients are
3,451 Original Medicare patients in 2024. Average age 76 · Under 65 4% · 85 and older 17% · Women 52% · Also on Medicaid 14% · Health risk score 1.38. At or below the middle of the specialty; the typical cardiology clinician is at 1.71.
Conditions among them: High blood pressure 73% · Coronary heart disease 47% · Atrial fibrillation 34% · Chronic kidney disease 28% · Diabetes 23% · Heart failure 23% · Cancer 18% · Depression 18% · COPD 11% · Stroke 11% · Dementia 10%.
The office billed $3,172,471, Medicare allowed $883,055 and paid $669,889; for 46,651 services of 46 kinds; $4,248 of it was for drugs given in the office and $665,641 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 3,451 | 46,651 | 76 | 1.38 | $3,172,471 | $669,889 |
| 2023 | 3,255 | 28,769 | 77 | 1.28 | $2,292,821 | $506,422 |
| 2022 | 3,181 | 30,048 | 77 | 1.29 | $2,445,784 | $573,476 |
| 2021 | 2,488 | 18,942 | 77 | 1.15 | $1,919,422 | $429,751 |
| 2020 | 1,888 | 17,814 | 77 | 1.13 | $1,558,333 | $321,142 |
| 2019 | 2,442 | 11,702 | 77 | 1.10 | $1,654,272 | $369,878 |
| 2018 | 2,224 | 3,630 | 76 | 1.10 | $1,135,339 | $294,226 |
| 2017 | 2,544 | 4,301 | 76 | 1.19 | $1,348,690 | $362,348 |
| 2016 | 2,585 | 4,644 | 76 | 1.24 | $1,272,802 | $341,974 |
| 2015 | 2,694 | 5,591 | 77 | 1.20 | $1,264,134 | $345,713 |
| 2014 | 2,157 | 4,095 | 76 | 1.18 | $1,251,014 | $340,450 |
| 2013 | 1,682 | 2,822 | 75 | 1.20 | $1,064,739 | $258,391 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 27 services
| Return visit (30+ min) | 602 | $123,825 | $111 |
| Ct scan of blood vessels and grafts of heart with contrast | 269 | $81,079 | $301 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 361 | $71,222 | $196 |
| Long return visit (40+ min) | 267 | $54,973 | $158 |
| Analysis of data from ct study of heart blood vessels to assess severity of heart artery disease, with interpretation and report | 36 | $41,696 | $1,127 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 116 | $27,124 | $234 |
| New patient visit (60+ min) | 139 | $26,477 | $190 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 50 | $13,164 | $110 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 975 | $10,227 | $7 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 65 | $10,203 | $157 |
| Ct scan of heart with evaluation of blood vessel calcium | 100 | $9,143 | $91 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 661 | $9,138 | $13 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 292 | $7,185 | $24 |
| Heart rhythm recording of continous external ekg over 8-15 days | 290 | $3,985 | $13 |
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 277 | $2,725 | $0 |
| Telephone medical discussion with physician, 21-30 minutes | 11 | $1,049 | $95 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 48 | $1,040 | $22 |
| Ambulatory blood pressure monitoring, 1 day or longer, with recording, scanning analysis, interpretation, and report | 19 | $876 | $46 |
| Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | 48 | $642 | $13 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 19 | $641 | $24 |
| Heart muscle strain imaging | 12 | $479 | $40 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 12 | $338 | $26 |
| Electrocardiogram (ecg) 2-day continuous | 16 | $323 | $20 |
| Blood test, clotting time | 46 | $311 | $4 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 13 | $307 | $24 |
| Anticoagulant management of patient taking warfarin | 27 | $281 | $8 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 13 | $223 | $17 |
2022: 24 services
| Return visit (30+ min) | 569 | $121,533 | $112 |
| Analysis of data from ct study of heart blood vessels to assess severity of heart artery disease, with interpretation and report | 87 | $91,123 | $1,047 |
| Ct scan of blood vessels and grafts of heart with contrast | 289 | $87,366 | $301 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 329 | $65,938 | $198 |
| Long return visit (40+ min) | 276 | $59,243 | $159 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 153 | $36,465 | $238 |
| New patient visit (60+ min) | 110 | $21,705 | $197 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 72 | $21,176 | $95 |
| Ct scan of heart with evaluation of blood vessel calcium | 165 | $16,004 | $97 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 61 | $11,990 | $182 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 1,125 | $11,805 | $7 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 578 | $7,712 | $13 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 168 | $4,202 | $25 |
| Heart rhythm recording of continous external ekg over 8-15 days | 160 | $2,455 | $15 |
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 275 | $2,150 | $0 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 65 | $1,365 | $20 |
| Ultrasound of heart, follow-up | 12 | $1,289 | $107 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 18 | $478 | $27 |
| Anticoagulant management of patient taking warfarin | 30 | $394 | $10 |
| Electrocardiogram (ecg) 2-day continuous | 19 | $383 | $20 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 19 | $329 | $17 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 11 | $305 | $28 |
| Blood test, clotting time | 48 | $292 | $4 |
| High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml | 12 | $147 | $0 |
2021: 24 services
| Return visit (30+ min) | 542 | $122,681 | $110 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 296 | $62,255 | $208 |
| Ct scan of blood vessels and grafts of heart with contrast | 186 | $56,640 | $305 |
| Long return visit (40+ min) | 226 | $47,881 | $163 |
| New patient visit (60+ min) | 151 | $30,809 | $204 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 114 | $28,294 | $248 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 65 | $11,899 | $180 |
| Analysis of data from ct study of heart blood vessels to assess severity of heart artery disease, with interpretation and report | 68 | $11,573 | $170 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 54 | $10,973 | $95 |
| Ct scan of heart with evaluation of blood vessel calcium | 95 | $9,404 | $99 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 595 | $8,448 | $14 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 230 | $5,926 | $25 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 493 | $4,873 | $8 |
| Heart rhythm recording of continous external ekg over 8-15 days | 210 | $3,500 | $16 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 70 | $2,319 | $21 |
| Telephone medical discussion with physician, 21-30 minutes | 12 | $1,394 | $87 |
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 173 | $1,352 | $0 |
| Blood test, clotting time | 61 | $571 | $4 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 22 | $524 | $24 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 17 | $496 | $28 |
| Electrocardiogram (ecg) 2-day continuous | 15 | $318 | $21 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 15 | $263 | $18 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 14 | $177 | $13 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring | 11 | $101 | $9 |
2020: 25 services
| Return visit (30+ min) | 447 | $75,499 | $94 |
| Ct scan of blood vessels and grafts of heart with contrast | 184 | $55,014 | $299 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 234 | $49,016 | $205 |
| Long return visit (40+ min) | 162 | $25,523 | $130 |
| New patient visit (60+ min) | 126 | $24,397 | $194 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 87 | $19,846 | $228 |
| Telephone medical discussion with physician, 21-30 minutes | 75 | $10,241 | $102 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 53 | $10,014 | $189 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 43 | $9,658 | $97 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 530 | $8,442 | $15 |
| Ct scan of heart with evaluation of blood vessel calcium | 51 | $4,571 | $90 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 178 | $4,505 | $25 |
| External ekg recording for more than 48 hours up to 21 days | 145 | $4,095 | $28 |
| Analysis of data from ct study of heart blood vessels to assess severity of heart artery disease, with interpretation and report | 57 | $2,663 | $47 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 216 | $2,225 | $8 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 49 | $1,579 | $22 |
| High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml | 122 | $1,431 | $0 |
| Ambulatory blood pressure monitoring, 1 day or longer, with recording, scanning analysis, interpretation, and report | 24 | $936 | $39 |
| Telephone medical discussion with physician, 11-20 minutes | 12 | $906 | $70 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 24 | $685 | $27 |
| Blood test, clotting time | 78 | $611 | $4 |
| Electrocardiogram (ecg) 2-day continuous | 14 | $408 | $27 |
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 60 | $396 | $0 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 14 | $380 | $25 |
| Injection, dobutamine hydrochloride, per 250 mg | 11 | $51 | None |
2019: 26 services
| Return visit (30+ min) | 436 | $81,547 | $93 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 355 | $72,829 | $202 |
| Long return visit (40+ min) | 254 | $46,754 | $130 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 180 | $41,722 | $232 |
| Ct scan of blood vessels and grafts of heart with contrast | 103 | $33,512 | $325 |
| New patient visit (60+ min) | 129 | $23,551 | $183 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 940 | $15,138 | $15 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 44 | $9,280 | $94 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 42 | $7,296 | $174 |
| External ekg recording for more than 48 hours up to 21 days | 209 | $5,882 | $27 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 209 | $5,230 | $24 |
| Ct scan of heart with evaluation of blood vessel calcium | 38 | $3,520 | $93 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 32 | $2,318 | $72 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 69 | $2,144 | $22 |
| Analysis of data from ct study of heart blood vessels to assess severity of heart artery disease, with interpretation and report | 41 | $1,913 | $47 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 164 | $1,658 | $8 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 19 | $1,241 | $65 |
| Ambulatory blood pressure monitoring, 1 day or longer, with recording, scanning analysis, interpretation, and report | 25 | $1,228 | $49 |
| High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml | 101 | $1,116 | $0 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 30 | $829 | $24 |
| Blood test, clotting time | 96 | $689 | $4 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring, transmission and review and report by health care professional | 23 | $563 | $23 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 34 | $468 | $14 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 12 | $287 | $24 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring | 22 | $229 | $10 |
| Injection, dobutamine hydrochloride, per 250 mg | 12 | $71 | None |
2018: 17 services
| Return visit (30+ min) | 410 | $71,354 | $90 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 343 | $70,444 | $204 |
| Long return visit (40+ min) | 224 | $39,860 | $123 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 170 | $38,908 | $228 |
| New patient visit (60+ min) | 94 | $16,711 | $178 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 929 | $14,298 | $15 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 47 | $8,793 | $94 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 42 | $8,016 | $178 |
| External ekg recording for more than 48 hours up to 21 days | 212 | $5,904 | $27 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 212 | $5,119 | $24 |
| Ultrasound of heart with probe in esophagus, with report | 13 | $3,473 | $248 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 25 | $2,087 | $83 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 23 | $1,570 | $68 |
| Ambulatory blood pressure monitoring, 1 day or longer, with recording, scanning analysis, interpretation, and report | 26 | $1,247 | $48 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 128 | $1,123 | $7 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 32 | $418 | $13 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 12 | $328 | $27 |
2017: 24 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 381 | $83,118 | $216 |
| Return visit (30+ min) | 380 | $66,009 | $89 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 205 | $54,420 | $260 |
| Long return visit (40+ min) | 213 | $39,095 | $125 |
| New patient visit (60+ min) | 110 | $19,241 | $175 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 34 | $16,455 | $484 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 978 | $13,879 | $14 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 41 | $8,881 | $93 |
| Ultrasound of heart with probe in esophagus, with report | 35 | $8,648 | $240 |
| External ekg recording for more than 48 hours up to 21 days | 274 | $7,621 | $27 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 274 | $6,687 | $24 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 34 | $6,393 | $95 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 27 | $5,439 | $181 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 63 | $4,942 | $77 |
| Injection, regadenoson, 0.1 mg | 29 | $4,379 | None |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 60 | $3,900 | $65 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 258 | $2,231 | $7 |
| Ultrasound of heart, follow-up | 11 | $1,332 | $111 |
| 3d radiographic procedure with computerized image postprocessing | 12 | $831 | $69 |
| 3d radiographic procedure | 13 | $323 | $23 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring, transmission and review and report by health care professional | 11 | $251 | $23 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 12 | $162 | $13 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring | 13 | $121 | $9 |
| Injection, dobutamine hydrochloride, per 250 mg | 12 | $53 | None |
2016: 27 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 316 | $69,372 | $218 |
| Return visit (30+ min) | 371 | $63,190 | $87 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 135 | $34,718 | $255 |
| Long return visit (40+ min) | 177 | $30,525 | $127 |
| New patient visit (60+ min) | 119 | $21,249 | $179 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 44 | $20,902 | $475 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 1,102 | $16,442 | $14 |
| External ekg recording for more than 48 hours up to 21 days | 354 | $10,175 | $27 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 49 | $9,444 | $93 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 354 | $8,854 | $24 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 44 | $8,397 | $95 |
| Ultrasound of heart with probe in esophagus, with report | 27 | $8,273 | $295 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 45 | $8,227 | $175 |
| Injection, regadenoson, 0.1 mg | 36 | $5,581 | None |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 64 | $5,184 | $81 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 62 | $3,952 | $64 |
| Ultrasound of heart during rest, exercise and/or drug-induced stress with report | 14 | $3,228 | $231 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 261 | $2,246 | $7 |
| Ultrasound of heart, follow-up | 11 | $1,362 | $113 |
| External shock to heart to regulate heart beat | 12 | $1,337 | $111 |
| Ultrasound of heart blood flow, valves and chambers | 13 | $698 | $54 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring, transmission and review and report by health care professional | 28 | $635 | $23 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 13 | $339 | $26 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 13 | $301 | $23 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring | 29 | $261 | $9 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 17 | $222 | $13 |
| Injection, dobutamine hydrochloride, per 250 mg | 11 | $47 | None |
2015: 23 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 292 | $67,615 | $231 |
| Return visit (30+ min) | 364 | $67,459 | $94 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 150 | $40,281 | $269 |
| Long return visit (40+ min) | 162 | $26,438 | $130 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 1,298 | $20,872 | $15 |
| New patient visit (60+ min) | 107 | $20,698 | $193 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 37 | $18,395 | $497 |
| Ultrasound of heart with probe in esophagus, with report | 41 | $14,368 | $319 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 59 | $11,722 | $98 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 37 | $9,782 | $132 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 101 | $8,896 | $85 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 36 | $7,021 | $190 |
| Ultrasound of heart during rest, exercise and/or drug-induced stress with report | 19 | $4,866 | $256 |
| External ekg recording for more than 48 hours up to 21 days | 165 | $4,833 | $29 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 163 | $4,139 | $25 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 50 | $3,066 | $61 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 321 | $2,869 | $7 |
| External ekg recording for more than 48 hours up to 21 days with analysis, report, review and interpretation | 26 | $2,213 | $85 |
| External shock to heart to regulate heart beat | 12 | $1,316 | $101 |
| Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 29 | $941 | None |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 36 | $480 | $13 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring, transmission and review and report by health care professional | 20 | $461 | $23 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring | 21 | $209 | $10 |
2014: 23 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 325 | $70,346 | $214 |
| Return visit (30+ min) | 315 | $52,791 | $89 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 146 | $37,910 | $256 |
| External ekg recording for more than 48 hours up to 21 days with analysis, report, review and interpretation | 142 | $34,319 | $235 |
| Long return visit (40+ min) | 182 | $32,327 | $127 |
| New patient visit (60+ min) | 113 | $19,961 | $177 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 38 | $18,272 | $469 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 887 | $13,130 | $14 |
| Ultrasound of heart with probe in esophagus, with report | 34 | $11,303 | $332 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 38 | $10,283 | $132 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 53 | $8,410 | $92 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 43 | $7,734 | $180 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 75 | $5,765 | $75 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 57 | $3,632 | $63 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 205 | $1,945 | $7 |
| Injection, adenosine for diagnostic use, 1 mg (not to be used to report any adenosine phosphate compounds, instead use a9270) | 27 | $1,595 | None |
| Ultrasound of heart blood flow, valves and chambers | 18 | $947 | $53 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 21 | $499 | $23 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 36 | $469 | $13 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 18 | $460 | $26 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring, transmission and review and report by health care professional | 11 | $249 | $23 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring | 11 | $102 | $9 |
| Injection, dobutamine hydrochloride, per 250 mg | 16 | $72 | None |
2013: 25 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 339 | $60,613 | $171 |
| Return visit (30+ min) | 307 | $51,707 | $88 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 118 | $26,063 | $217 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 43 | $20,431 | $330 |
| Long return visit (40+ min) | 125 | $18,593 | $114 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 107 | $13,428 | $84 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 627 | $10,499 | $16 |
| External ekg recording for more than 48 hours up to 21 days with analysis, report, review and interpretation | 35 | $8,464 | $242 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 43 | $8,399 | $131 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 41 | $7,982 | $90 |
| Ultrasound of heart with probe in esophagus, with report | 24 | $7,378 | $295 |
| New patient visit (60+ min) | 37 | $6,478 | $175 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 21 | $3,688 | $176 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 56 | $3,445 | $60 |
| Injection, adenosine for diagnostic use, 30 mg (not to be used to report any adenosine phosphate compounds; instead use a9270) | 35 | $2,960 | None |
| Extended office or other outpatient service, first hour | 15 | $1,383 | $86 |
| Emergency department visit with moderate level of medical decision making | 11 | $1,035 | $94 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 112 | $1,009 | $7 |
| Ultrasound of heart blood flow, valves and chambers | 17 | $723 | $43 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 17 | $357 | $21 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 18 | $348 | $19 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 14 | $230 | $15 |
| Blood test, clotting time | 26 | $144 | $5 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 11 | $140 | $13 |
| Injection, dobutamine hydrochloride, per 250 mg | 16 | $93 | None |
Medicaid work
$13,232 in 2024
Medicaid paid $13,232 for 1,115 billed services this clinician did in 2024, up to 114 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 1,102 | $12,920 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 13 | $312 |
| 2024 | 1,115 | 2 | 114 | $13,232 |
| 2023 | 590 | 3 | 106 | $4,931 |
| 2022 | 679 | 1 | 136 | $6,586 |
| 2021 | 330 | 2 | 65 | $3,474 |
| 2020 | 80 | 2 | 21 | $1,027 |
| 2019 | 32 | 1 | 20 | $612 |
| 2018 | 25 | 1 | 13 | $460 |
See the largest Medicaid services in earlier years
2023
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 527 | $3,731 |
| Return visit (30+ min) | 47 | $862 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 16 | $338 |
2022
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 679 | $6,586 |
2021
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 316 | $3,253 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 14 | $221 |
2020
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 68 | $738 |
| Return visit (30+ min) | 12 | $289 |
2019
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 32 | $612 |
2018
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 25 | $460 |
Drugs they prescribed that Part D paid
$2,177,495
Pharmacies billed $2,177,495 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 6,829) in 2024. At or below the middle of the specialty; the typical cardiology clinician is at 0%.
5,751 generic and 1,078 brand-name prescriptions · $2,177,495 in drug cost · 21 antibiotic prescriptions to 13 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Vyndaqel | 21 | $795,479 | $37,880 |
| Eliquis | 522 | $739,166 | $1,416 |
| Xarelto | 114 | $154,754 | $1,357 |
| Jardiance | 102 | $151,067 | $1,481 |
| Repatha Sureclick | 107 | $92,158 | $861 |
See all 49 drugs
| Vyndaqel | 21 | $795,479 | $37,880 |
| Eliquis | 522 | $739,166 | $1,416 |
| Xarelto | 114 | $154,754 | $1,357 |
| Jardiance | 102 | $151,067 | $1,481 |
| Repatha Sureclick | 107 | $92,158 | $861 |
| Entresto | 54 | $76,554 | $1,418 |
| Praluent | 38 | $22,005 | $579 |
| Repatha Pushtronex | 21 | $19,781 | $942 |
| Rosuvastatin | 859 | $16,611 | $19 |
| Atorvastatin | 966 | $10,401 | $11 |
| Metoprolol | 476 | $8,391 | $18 |
| Losartan | 522 | $6,202 | $12 |
| Icosapent Ethyl | 12 | $5,916 | $493 |
| Ezetimibe | 165 | $5,770 | $35 |
| Spironolactone | 237 | $3,281 | $14 |
| Carvedilol | 226 | $2,538 | $11 |
| Amlodipine Besylate | 344 | $2,510 | $7 |
| Potassium Chloride | 55 | $2,210 | $40 |
| Diltiazem 24hr Er (Cd) | 58 | $1,915 | $33 |
| Lisinopril | 202 | $1,795 | $9 |
| Losartan-Hydrochlorothiazide | 104 | $1,696 | $16 |
| Torsemide | 39 | $1,600 | $41 |
| Furosemide | 123 | $1,213 | $10 |
| Metoprolol | 393 | $1,187 | $3 |
| Clopidogrel | 66 | $1,070 | $16 |
| Hydrochlorothiazide | 190 | $1,061 | $6 |
| Amiodarone | 49 | $970 | $20 |
| Eplerenone | 11 | $946 | $86 |
| Benazepril | 27 | $903 | $33 |
| Pravastatin | 38 | $890 | $23 |
| Olmesartan Medoxomil | 27 | $859 | $32 |
| Valsartan | 33 | $845 | $26 |
| Digoxin | 21 | $831 | $40 |
| Hydralazine | 40 | $780 | $19 |
| Spironolactone-Hctz | 16 | $625 | $39 |
| Atenolol | 54 | $586 | $11 |
| Irbesartan | 21 | $491 | $23 |
| Lisinopril-Hydrochlorothiazide | 24 | $382 | $16 |
| Diltiazem 24hr Er | 15 | $362 | $24 |
| Warfarin | 27 | $324 | $12 |
| Flecainide Acetate | 11 | $219 | $20 |
| Verapamil Er | 12 | $215 | $18 |
| Simvastatin | 49 | $200 | $4 |
| Nitroglycerin | 23 | $166 | $7 |
| Diltiazem | 12 | $136 | $11 |
| Chlorthalidone | 11 | $98 | $9 |
| Prednisone | 11 | $57 | $5 |
| Amoxicillin | 19 | $46 | $2 |
| Diltiazem 24hr Er (La) | 11 | $0 | $0 |
Year by year
| 2024 | 6,829 | 1,135 | 0% (0) | 16% | $2,177,495 |
| 2023 | 6,371 | 1,057 | 0% (0) | 15% | $1,571,774 |
| 2022 | 5,978 | 934 | 0% (0) | 15% | $1,324,312 |
| 2021 | 5,141 | 760 | 0% (0) | 15% | $873,563 |
| 2020 | 4,713 | 679 | 0% (0) | 16% | $885,423 |
| 2019 | 4,460 | 618 | 0% (0) | 17% | $592,378 |
| 2018 | 4,383 | 596 | 0% (0) | 16% | $450,120 |
| 2017 | 4,286 | 518 | None | 21% | $384,556 |
| 2016 | 3,719 | 443 | 0% (0) | 22% | $293,719 |
| 2015 | 3,114 | 373 | 0% (0) | 25% | $218,547 |
| 2014 | 2,987 | 379 | None | 24% | $199,921 |
| 2013 | 2,981 | 332 | 0% (0) | 22% | $169,604 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 46 drugs
| Eliquis | 487 | $665,229 | $1,366 |
| Vyndaqel | 13 | $296,165 | $22,782 |
| Xarelto | 126 | $180,644 | $1,434 |
| Jardiance | 53 | $95,475 | $1,801 |
| Entresto | 49 | $62,678 | $1,279 |
| Repatha Sureclick | 60 | $58,630 | $977 |
| Repatha Pushtronex | 52 | $48,373 | $930 |
| Rosuvastatin | 678 | $18,779 | $28 |
| Atorvastatin | 985 | $14,024 | $14 |
| Metoprolol | 513 | $10,844 | $21 |
| Ezetimibe | 122 | $9,580 | $79 |
| Losartan | 491 | $8,332 | $17 |
| Diltiazem 24hr Er (Cd) | 65 | $3,564 | $55 |
| Amlodipine Besylate | 341 | $3,409 | $10 |
| Potassium Chloride | 49 | $3,274 | $67 |
| Carvedilol | 233 | $3,122 | $13 |
| Lisinopril | 220 | $2,380 | $11 |
| Eplerenone | 13 | $2,104 | $162 |
| Spironolactone | 190 | $2,094 | $11 |
| Losartan-Hydrochlorothiazide | 71 | $2,061 | $29 |
| Hydralazine | 55 | $2,043 | $37 |
| Torsemide | 47 | $1,705 | $36 |
| Valsartan | 28 | $1,510 | $54 |
| Furosemide | 138 | $1,409 | $10 |
| Irbesartan | 31 | $1,375 | $44 |
| Clopidogrel | 52 | $1,349 | $26 |
| Digoxin | 28 | $1,222 | $44 |
| Metoprolol | 355 | $1,182 | $3 |
| Pravastatin | 44 | $1,163 | $26 |
| Olmesartan Medoxomil | 22 | $1,044 | $47 |
| Hydrochlorothiazide | 188 | $897 | $5 |
| Spironolactone-Hctz | 14 | $893 | $64 |
| Amiodarone | 33 | $833 | $25 |
| Atenolol | 53 | $690 | $13 |
| Warfarin | 23 | $635 | $28 |
| Benazepril | 16 | $600 | $38 |
| Verapamil Er | 13 | $568 | $44 |
| Fenofibrate | 13 | $549 | $42 |
| Isosorbide Mononitrate Er | 13 | $520 | $40 |
| Simvastatin | 58 | $405 | $7 |
| Diltiazem 24hr Er | 14 | $397 | $28 |
| Ramipril | 21 | $396 | $19 |
| Lisinopril-Hydrochlorothiazide | 26 | $386 | $15 |
| Nitroglycerin | 12 | $217 | $18 |
| Chlorthalidone | 11 | $137 | $12 |
| Amoxicillin | 13 | $19 | $1 |
2022: 46 drugs
| Eliquis | 474 | $605,391 | $1,277 |
| Vyndaqel | 12 | $258,838 | $21,570 |
| Xarelto | 129 | $176,582 | $1,369 |
| Repatha Sureclick | 63 | $52,858 | $839 |
| Entresto | 34 | $29,516 | $868 |
| Rosuvastatin | 556 | $24,555 | $44 |
| Jardiance | 13 | $22,313 | $1,716 |
| Repatha Pushtronex | 25 | $20,321 | $813 |
| Atorvastatin | 984 | $12,013 | $12 |
| Metoprolol | 490 | $10,037 | $20 |
| Praluent | 11 | $7,031 | $639 |
| Losartan | 439 | $6,381 | $15 |
| Diltiazem 24hr Er (Cd) | 88 | $4,663 | $53 |
| Ezetimibe | 75 | $4,098 | $55 |
| Amlodipine Besylate | 343 | $3,041 | $9 |
| Carvedilol | 230 | $3,000 | $13 |
| Potassium Chloride | 66 | $2,724 | $41 |
| Valsartan | 37 | $2,713 | $73 |
| Lisinopril | 222 | $2,287 | $10 |
| Spironolactone | 151 | $2,275 | $15 |
| Losartan-Hydrochlorothiazide | 64 | $2,215 | $35 |
| Irbesartan | 31 | $1,849 | $60 |
| Hydralazine | 53 | $1,789 | $34 |
| Digoxin | 32 | $1,700 | $53 |
| Olmesartan Medoxomil | 20 | $1,593 | $80 |
| Furosemide | 154 | $1,581 | $10 |
| Torsemide | 41 | $1,572 | $38 |
| Pravastatin | 58 | $1,267 | $22 |
| Amiodarone | 40 | $1,149 | $29 |
| Clopidogrel | 53 | $1,031 | $19 |
| Fenofibrate | 20 | $996 | $50 |
| Metoprolol | 292 | $976 | $3 |
| Hydrochlorothiazide | 158 | $919 | $6 |
| Warfarin | 29 | $909 | $31 |
| Atenolol | 56 | $821 | $15 |
| Chlorthalidone | 19 | $772 | $41 |
| Diltiazem 24hr Er | 15 | $763 | $51 |
| Spironolactone-Hctz | 13 | $744 | $57 |
| Simvastatin | 53 | $733 | $14 |
| Lisinopril-Hydrochlorothiazide | 34 | $373 | $11 |
| Benazepril | 19 | $370 | $19 |
| Verapamil Er | 11 | $357 | $32 |
| Ramipril | 18 | $279 | $15 |
| Lovastatin | 11 | $223 | $20 |
| Nitroglycerin | 15 | $206 | $14 |
| Amoxicillin | 19 | $50 | $3 |
2021: 46 drugs
| Eliquis | 421 | $489,763 | $1,163 |
| Xarelto | 121 | $156,495 | $1,293 |
| Repatha Sureclick | 66 | $40,500 | $614 |
| Rosuvastatin | 357 | $16,901 | $47 |
| Atorvastatin | 904 | $13,918 | $15 |
| Repatha Pushtronex | 16 | $13,651 | $853 |
| Praluent | 21 | $13,314 | $634 |
| Entresto | 16 | $9,932 | $621 |
| Metoprolol | 421 | $9,686 | $23 |
| Vascepa | 13 | $8,922 | $686 |
| Losartan | 346 | $5,915 | $17 |
| Diltiazem 24hr Er (Cd) | 69 | $4,967 | $72 |
| Valsartan | 42 | $3,272 | $78 |
| Ezetimibe | 43 | $3,015 | $70 |
| Amlodipine Besylate | 284 | $2,798 | $10 |
| Lisinopril | 221 | $2,630 | $12 |
| Carvedilol | 168 | $2,336 | $14 |
| Losartan-Hydrochlorothiazide | 50 | $2,132 | $43 |
| Spironolactone | 118 | $1,789 | $15 |
| Hydralazine | 69 | $1,780 | $26 |
| Digoxin | 40 | $1,613 | $40 |
| Potassium Chloride | 47 | $1,483 | $32 |
| Spironolactone-Hctz | 24 | $1,411 | $59 |
| Furosemide | 135 | $1,346 | $10 |
| Torsemide | 22 | $1,334 | $61 |
| Irbesartan | 31 | $1,160 | $37 |
| Pravastatin | 48 | $1,140 | $24 |
| Amiodarone | 31 | $1,131 | $36 |
| Diltiazem 24hr Er | 16 | $1,101 | $69 |
| Metoprolol | 240 | $1,054 | $4 |
| Clopidogrel | 58 | $963 | $17 |
| Chlorthalidone | 17 | $931 | $55 |
| Hydrochlorothiazide | 172 | $888 | $5 |
| Simvastatin | 68 | $770 | $11 |
| Atenolol | 47 | $598 | $13 |
| Cartia Xt | 11 | $528 | $48 |
| Warfarin | 21 | $432 | $21 |
| Fenofibrate | 15 | $424 | $28 |
| Ramipril | 20 | $347 | $17 |
| Benazepril | 16 | $336 | $21 |
| Enalapril Maleate | 22 | $333 | $15 |
| Lisinopril-Hydrochlorothiazide | 14 | $253 | $18 |
| Nitroglycerin | 14 | $252 | $18 |
| Isosorbide Mononitrate Er | 15 | $235 | $16 |
| Lovastatin | 12 | $230 | $19 |
| Amoxicillin | 18 | $33 | $2 |
2020: 42 drugs
| Eliquis | 390 | $367,934 | $943 |
| Vyndaqel | 11 | $204,472 | $18,588 |
| Xarelto | 104 | $129,752 | $1,248 |
| Repatha Sureclick | 71 | $33,376 | $470 |
| Atorvastatin | 872 | $16,025 | $18 |
| Rosuvastatin | 225 | $13,450 | $60 |
| Metoprolol | 421 | $12,995 | $31 |
| Praluent | 21 | $10,103 | $481 |
| Diltiazem 24hr Er (Cd) | 81 | $7,949 | $98 |
| Losartan | 341 | $6,156 | $18 |
| Valsartan | 44 | $4,057 | $92 |
| Losartan-Hydrochlorothiazide | 46 | $2,866 | $62 |
| Ezetimibe | 32 | $2,790 | $87 |
| Amlodipine Besylate | 256 | $2,261 | $9 |
| Lisinopril | 197 | $2,118 | $11 |
| Carvedilol | 138 | $1,902 | $14 |
| Digoxin | 42 | $1,806 | $43 |
| Amiodarone | 26 | $1,658 | $64 |
| Spironolactone-Hctz | 24 | $1,590 | $66 |
| Spironolactone | 107 | $1,517 | $14 |
| Furosemide | 146 | $1,430 | $10 |
| Potassium Chloride | 35 | $1,306 | $37 |
| Hydralazine | 55 | $1,272 | $23 |
| Irbesartan | 30 | $1,174 | $39 |
| Hydrochlorothiazide | 162 | $1,107 | $7 |
| Clopidogrel | 54 | $1,028 | $19 |
| Chlorthalidone | 18 | $1,013 | $56 |
| Diltiazem 24hr Er | 19 | $892 | $47 |
| Pravastatin | 44 | $802 | $18 |
| Metoprolol | 172 | $720 | $4 |
| Simvastatin | 78 | $716 | $9 |
| Atenolol | 55 | $607 | $11 |
| Torsemide | 14 | $494 | $35 |
| Warfarin | 25 | $469 | $19 |
| Irbesartan-Hydrochlorothiazide | 11 | $390 | $35 |
| Benazepril | 21 | $386 | $18 |
| Lisinopril-Hydrochlorothiazide | 22 | $288 | $13 |
| Isosorbide Mononitrate Er | 12 | $265 | $22 |
| Lovastatin | 15 | $240 | $16 |
| Ramipril | 17 | $220 | $13 |
| Nitroglycerin | 13 | $162 | $12 |
| Enalapril Maleate | 13 | $86 | $7 |
2019: 45 drugs
| Eliquis | 341 | $276,111 | $810 |
| Xarelto | 136 | $139,348 | $1,025 |
| Repatha Sureclick | 37 | $31,616 | $854 |
| Praluent | 37 | $28,223 | $763 |
| Atorvastatin | 777 | $15,006 | $19 |
| Metoprolol | 391 | $11,520 | $29 |
| Rosuvastatin | 172 | $9,409 | $55 |
| Diltiazem 24hr Er (Cd) | 84 | $9,088 | $108 |
| Losartan | 348 | $4,984 | $14 |
| Brilinta | 11 | $4,013 | $365 |
| Ezetimibe | 31 | $3,358 | $108 |
| Spironolactone-Hctz | 35 | $2,409 | $69 |
| Lisinopril | 204 | $2,293 | $11 |
| Amlodipine Besylate | 256 | $2,060 | $8 |
| Digoxin | 33 | $1,917 | $58 |
| Carvedilol | 131 | $1,742 | $13 |
| Potassium Chloride | 44 | $1,447 | $33 |
| Furosemide | 142 | $1,440 | $10 |
| Valsartan | 18 | $1,300 | $72 |
| Chlorthalidone | 21 | $1,268 | $60 |
| Spironolactone | 98 | $1,208 | $12 |
| Irbesartan | 38 | $1,134 | $30 |
| Cartia Xt | 26 | $1,123 | $43 |
| Felodipine Er | 16 | $1,091 | $68 |
| Pravastatin | 45 | $1,035 | $23 |
| Losartan-Hydrochlorothiazide | 68 | $1,031 | $15 |
| Metoprolol | 172 | $1,021 | $6 |
| Amiodarone | 26 | $1,018 | $39 |
| Fenofibrate | 12 | $948 | $79 |
| Simvastatin | 70 | $830 | $12 |
| Hydrochlorothiazide | 139 | $758 | $5 |
| Clopidogrel | 34 | $714 | $21 |
| Hydralazine | 38 | $654 | $17 |
| Atenolol | 48 | $613 | $13 |
| Warfarin | 22 | $514 | $23 |
| Dilt-Xr | 13 | $468 | $36 |
| Irbesartan-Hydrochlorothiazide | 12 | $467 | $39 |
| Ramipril | 33 | $426 | $13 |
| Benazepril | 26 | $411 | $16 |
| Lisinopril-Hydrochlorothiazide | 33 | $361 | $11 |
| Nitroglycerin | 20 | $348 | $17 |
| Isosorbide Mononitrate Er | 14 | $273 | $20 |
| Lovastatin | 11 | $153 | $14 |
| Clonidine | 12 | $98 | $8 |
| Amoxicillin | 23 | $79 | $3 |
2018: 46 drugs
| Eliquis | 279 | $182,266 | $653 |
| Xarelto | 173 | $137,485 | $795 |
| Atorvastatin | 782 | $16,007 | $20 |
| Pradaxa | 16 | $14,935 | $933 |
| Metoprolol | 400 | $13,118 | $33 |
| Diltiazem 24hr Er (Cd) | 92 | $8,463 | $92 |
| Ezetimibe | 38 | $6,811 | $179 |
| Rosuvastatin | 116 | $4,567 | $39 |
| Losartan | 294 | $3,263 | $11 |
| Bumetanide | 14 | $3,079 | $220 |
| Coreg | 12 | $2,755 | $230 |
| Digoxin | 34 | $2,312 | $68 |
| Amiodarone | 19 | $2,311 | $122 |
| Cartia Xt | 49 | $2,279 | $47 |
| Lisinopril | 207 | $2,183 | $11 |
| Spironolactone-Hctz | 39 | $2,183 | $56 |
| Valsartan | 33 | $1,809 | $55 |
| Amlodipine Besylate | 246 | $1,705 | $7 |
| Pravastatin | 44 | $1,459 | $33 |
| Furosemide | 220 | $1,287 | $6 |
| Chlorthalidone | 21 | $1,275 | $61 |
| Metoprolol | 197 | $1,162 | $6 |
| Carvedilol | 104 | $1,142 | $11 |
| Losartan-Hydrochlorothiazide | 70 | $1,115 | $16 |
| Digox | 12 | $1,072 | $89 |
| Labetalol | 26 | $1,040 | $40 |
| Atenolol | 69 | $947 | $14 |
| Simvastatin | 73 | $901 | $12 |
| Spironolactone | 79 | $876 | $11 |
| Clopidogrel | 42 | $855 | $20 |
| Potassium Chloride | 37 | $808 | $22 |
| Hydrochlorothiazide | 137 | $731 | $5 |
| Felodipine Er | 21 | $611 | $29 |
| Irbesartan | 30 | $583 | $19 |
| Diltiazem 24hr Er | 12 | $575 | $48 |
| Ramipril | 28 | $475 | $17 |
| Hydralazine | 34 | $453 | $13 |
| Dilt-Xr | 11 | $366 | $33 |
| Warfarin | 14 | $355 | $25 |
| Benazepril | 21 | $307 | $15 |
| Nitroglycerin | 16 | $258 | $16 |
| Lisinopril-Hydrochlorothiazide | 32 | $201 | $6 |
| Isosorbide Mononitrate Er | 12 | $197 | $16 |
| Clonidine | 12 | $148 | $12 |
| Enalapril Maleate | 13 | $119 | $9 |
| Amoxicillin | 11 | $54 | $5 |
2017: 43 drugs
| Eliquis | 265 | $136,350 | $515 |
| Xarelto | 176 | $120,127 | $683 |
| Pradaxa | 22 | $16,332 | $742 |
| Metoprolol | 475 | $13,771 | $29 |
| Atorvastatin | 770 | $13,164 | $17 |
| Ezetimibe | 28 | $4,937 | $176 |
| Diltiazem 24hr Er | 85 | $4,538 | $53 |
| Rosuvastatin | 46 | $3,672 | $80 |
| Diltiazem 24hr Cd | 22 | $3,070 | $140 |
| Valsartan | 52 | $2,678 | $51 |
| Losartan | 234 | $2,648 | $11 |
| Digoxin | 50 | $2,559 | $51 |
| Spironolactone-Hctz | 26 | $1,626 | $63 |
| Cartia Xt | 65 | $1,608 | $25 |
| Lisinopril | 206 | $1,494 | $7 |
| Fenofibrate | 11 | $1,436 | $131 |
| Bumetanide | 15 | $1,353 | $90 |
| Pravastatin | 49 | $1,213 | $25 |
| Amlodipine Besylate | 219 | $1,194 | $5 |
| Carvedilol | 144 | $1,168 | $8 |
| Digox | 16 | $1,148 | $72 |
| Furosemide | 203 | $1,115 | $5 |
| Losartan-Hydrochlorothiazide | 81 | $951 | $12 |
| Metoprolol | 182 | $920 | $5 |
| Atenolol | 84 | $852 | $10 |
| Potassium Chloride | 32 | $845 | $26 |
| Labetalol | 18 | $764 | $42 |
| Spironolactone | 78 | $728 | $9 |
| Chlorthalidone | 12 | $723 | $60 |
| Simvastatin | 87 | $674 | $8 |
| Warfarin | 38 | $600 | $16 |
| Enalapril Maleate | 16 | $557 | $35 |
| Nitroglycerin | 23 | $532 | $23 |
| Ramipril | 35 | $456 | $13 |
| Hydrochlorothiazide | 87 | $433 | $5 |
| Hydralazine | 25 | $360 | $14 |
| Isosorbide Mononitrate Er | 15 | $277 | $18 |
| Clopidogrel | 20 | $266 | $13 |
| Valsartan-Hydrochlorothiazide | 14 | $233 | $17 |
| Lisinopril-Hydrochlorothiazide | 26 | $212 | $8 |
| Amiodarone | 12 | $178 | $15 |
| Benazepril | 16 | $171 | $11 |
| Clonidine | 13 | $120 | $9 |
2016: 39 drugs
| Xarelto | 203 | $103,550 | $510 |
| Eliquis | 140 | $57,861 | $413 |
| Pradaxa | 17 | $14,044 | $826 |
| Crestor | 26 | $13,483 | $519 |
| Metoprolol | 434 | $12,550 | $29 |
| Atorvastatin | 612 | $10,955 | $18 |
| Zetia | 23 | $10,104 | $439 |
| Valsartan | 53 | $7,151 | $135 |
| Diltiazem 24hr Er | 70 | $6,357 | $91 |
| Losartan | 239 | $2,674 | $11 |
| Digoxin | 63 | $2,338 | $37 |
| Clonidine | 17 | $2,252 | $132 |
| Bumetanide | 15 | $1,917 | $128 |
| Amlodipine Besylate | 197 | $1,501 | $8 |
| Lisinopril | 182 | $1,412 | $8 |
| Spironolactone-Hctz | 32 | $1,384 | $43 |
| Pravastatin | 36 | $1,380 | $38 |
| Carvedilol | 128 | $1,142 | $9 |
| Cartia Xt | 41 | $997 | $24 |
| Digox | 22 | $966 | $44 |
| Metoprolol | 177 | $959 | $5 |
| Simvastatin | 104 | $947 | $9 |
| Spironolactone | 77 | $807 | $10 |
| Diltiazem 24hr Cd | 25 | $780 | $31 |
| Furosemide | 148 | $734 | $5 |
| Atenolol | 74 | $719 | $10 |
| Ramipril | 37 | $678 | $18 |
| Losartan-Hydrochlorothiazide | 61 | $614 | $10 |
| Potassium Chloride | 29 | $510 | $18 |
| Clopidogrel | 26 | $485 | $19 |
| Hydrochlorothiazide | 79 | $452 | $6 |
| Warfarin | 32 | $437 | $14 |
| Lisinopril-Hydrochlorothiazide | 13 | $306 | $24 |
| Doxazosin Mesylate | 11 | $262 | $24 |
| Nitrostat | 11 | $260 | $24 |
| Valsartan-Hydrochlorothiazide | 15 | $253 | $17 |
| Dilt-Xr | 11 | $237 | $22 |
| Amiodarone | 11 | $135 | $12 |
| Benazepril | 11 | $133 | $12 |
2015: 42 drugs
| Xarelto | 213 | $89,817 | $422 |
| Eliquis | 61 | $21,763 | $357 |
| Metoprolol | 318 | $10,960 | $34 |
| Crestor | 23 | $10,502 | $457 |
| Pradaxa | 24 | $9,423 | $393 |
| Atorvastatin | 488 | $9,421 | $19 |
| Diltiazem 24hr Er | 34 | $4,763 | $140 |
| Valsartan | 24 | $3,485 | $145 |
| Coreg | 14 | $1,981 | $142 |
| Digoxin | 55 | $1,968 | $36 |
| Losartan | 190 | $1,796 | $9 |
| Diltiazem Er | 38 | $1,713 | $45 |
| Potassium Chloride | 50 | $1,557 | $31 |
| Bumetanide | 11 | $1,464 | $133 |
| Spironolactone-Hctz | 22 | $1,391 | $63 |
| Cartia Xt | 41 | $1,253 | $31 |
| Pravastatin | 31 | $1,227 | $40 |
| Diltiazem 24hr Cd | 28 | $1,128 | $40 |
| Warfarin | 64 | $1,114 | $17 |
| Carvedilol | 143 | $1,114 | $8 |
| Lisinopril | 153 | $1,013 | $7 |
| Furosemide | 163 | $953 | $6 |
| Digox | 26 | $926 | $36 |
| Amlodipine Besylate | 114 | $859 | $8 |
| Simvastatin | 112 | $821 | $7 |
| Metoprolol | 111 | $785 | $7 |
| Valsartan-Hydrochlorothiazide | 15 | $696 | $46 |
| Spironolactone | 76 | $567 | $7 |
| Ramipril | 45 | $557 | $12 |
| Atenolol | 71 | $546 | $8 |
| Hydrochlorothiazide | 57 | $388 | $7 |
| Dilt-Xr | 11 | $383 | $35 |
| Hydralazine | 15 | $319 | $21 |
| Isosorbide Mononitrate Er | 19 | $296 | $16 |
| Losartan-Hydrochlorothiazide | 34 | $273 | $8 |
| Triamterene-Hydrochlorothiazid | 15 | $248 | $17 |
| Verapamil Er | 12 | $231 | $19 |
| Clopidogrel | 14 | $229 | $16 |
| Nitrostat | 13 | $220 | $17 |
| Lovastatin | 12 | $151 | $13 |
| Benazepril | 16 | $150 | $9 |
| Lisinopril-Hydrochlorothiazide | 15 | $128 | $9 |
2014: 41 drugs
| Xarelto | 143 | $51,001 | $357 |
| Pradaxa | 52 | $23,283 | $448 |
| Diovan | 30 | $17,051 | $568 |
| Metoprolol | 330 | $13,498 | $41 |
| Eliquis | 39 | $12,856 | $330 |
| Atorvastatin | 425 | $11,111 | $26 |
| Crestor | 23 | $7,635 | $332 |
| Zetia | 30 | $7,031 | $234 |
| Diltiazem 24hr Er | 65 | $6,639 | $102 |
| Diltiazem Er | 53 | $2,555 | $48 |
| Losartan | 169 | $2,034 | $12 |
| Coreg | 13 | $2,031 | $156 |
| Carvedilol | 130 | $1,679 | $13 |
| Pravastatin | 32 | $1,571 | $49 |
| Simvastatin | 147 | $1,332 | $9 |
| Spironolactone-Hctz | 48 | $1,285 | $27 |
| Digoxin | 29 | $1,249 | $43 |
| Lisinopril | 162 | $1,148 | $7 |
| Diltiazem 24hr Cd | 33 | $1,114 | $34 |
| Amlodipine Besylate | 113 | $1,105 | $10 |
| Digox | 31 | $1,048 | $34 |
| Warfarin | 51 | $826 | $16 |
| Metoprolol | 89 | $796 | $9 |
| Potassium Chloride | 32 | $753 | $24 |
| Atenolol | 92 | $716 | $8 |
| Furosemide | 134 | $649 | $5 |
| Spironolactone | 57 | $614 | $11 |
| Clopidogrel | 30 | $589 | $20 |
| Verapamil Er | 19 | $580 | $31 |
| Cartia Xt | 15 | $530 | $35 |
| Losartan-Hydrochlorothiazide | 37 | $448 | $12 |
| Hydralazine | 17 | $412 | $24 |
| Isosorbide Mononitrate Er | 21 | $373 | $18 |
| Ramipril | 19 | $329 | $17 |
| Hydrochlorothiazide | 46 | $329 | $7 |
| Lovastatin | 14 | $263 | $19 |
| Enalapril Maleate | 15 | $258 | $17 |
| Benazepril | 13 | $207 | $16 |
| Triamterene-Hydrochlorothiazid | 11 | $201 | $18 |
| Nitrostat | 15 | $188 | $13 |
| Lisinopril-Hydrochlorothiazide | 20 | $175 | $9 |
2013: 44 drugs
| Pradaxa | 86 | $31,020 | $361 |
| Diovan | 58 | $19,476 | $336 |
| Atorvastatin | 445 | $18,389 | $41 |
| Xarelto | 52 | $15,614 | $300 |
| Metoprolol | 339 | $15,310 | $45 |
| Diltiazem 24hr Er | 67 | $8,404 | $125 |
| Zetia | 34 | $8,204 | $241 |
| Crestor | 15 | $4,119 | $275 |
| Clopidogrel | 33 | $3,039 | $92 |
| Carvedilol | 153 | $2,658 | $17 |
| Losartan | 119 | $2,625 | $22 |
| Lipitor | 11 | $2,555 | $232 |
| Simvastatin | 187 | $2,173 | $12 |
| Lisinopril | 193 | $1,925 | $10 |
| Diltiazem Er | 37 | $1,918 | $52 |
| Coreg | 11 | $1,682 | $153 |
| Metoprolol | 127 | $1,456 | $11 |
| Diltiazem 24hr Cd | 33 | $1,329 | $40 |
| Pravastatin | 25 | $1,131 | $45 |
| Amlodipine Besylate | 100 | $1,055 | $11 |
| Cartia Xt | 19 | $889 | $47 |
| Spironolactone-Hctz | 42 | $794 | $19 |
| Spironolactone | 51 | $790 | $15 |
| Atenolol | 88 | $720 | $8 |
| Verapamil Er | 16 | $658 | $41 |
| Losartan-Hydrochlorothiazide | 24 | $630 | $26 |
| Lovastatin | 24 | $532 | $22 |
| Potassium Chloride | 15 | $513 | $34 |
| Warfarin | 49 | $498 | $10 |
| Lanoxin | 12 | $473 | $39 |
| Ramipril | 24 | $468 | $19 |
| Isosorbide Mononitrate Er | 23 | $449 | $20 |
| Furosemide | 81 | $401 | $5 |
| Hydralazine | 14 | $401 | $29 |
| Benazepril | 29 | $353 | $12 |
| Amiodarone | 25 | $297 | $12 |
| Hydrochlorothiazide | 55 | $261 | $5 |
| Nitrostat | 21 | $234 | $11 |
| Gemfibrozil | 11 | $219 | $20 |
| Enalapril Maleate | 17 | $200 | $12 |
| Digoxin | 11 | $152 | $14 |
| Triamterene-Hctz | 11 | $135 | $12 |
| Digox | 20 | $120 | $6 |
| Indapamide | 18 | $114 | $6 |
Money from drug and device companies
$119 in 2025
| 2025 | 3 | 4 | None | $119 |
| 2024 | 1 | 1 | None | $26 |
| 2023 | 2 | 2 | None | $48 |
| 2022 | 2 | 3 | None | $94 |
| 2021 | 2 | 3 | None | $65 |
| 2019 | 1 | 1 | None | $22 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Heartflow | Ffrct | $61 | 2 payments
|
| Novartis Pharmaceuticals | Leqvio | $30 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | Eliquis | $29 | 1 payment
|
See all 4 published payments
| E.R. Squibb & Sons L.L.C. | Meals · 2025-12-02 | Eliquis | $29 |
| Heartflow | Meals · 2025-11-25 | Ffrct | $25 |
| Novartis Pharmaceuticals | Meals · 2025-07-31 | Leqvio | $30 |
| Heartflow | Meals · 2025-04-16 | Ffrct | $36 |
See earlier years (2024, 2023, 2022, 2021, 2019)
2024: $26
| Heartflow | Ffrct | $26 | 1 payment
|
2023: $48
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $26 | 1 payment
|
| Amgen | Repatha | $22 | 1 payment
|
2022: $94
| HeartFlow | Ffrct | $74 | 2 payments
|
| Abbott Laboratories | Mitraclip | $20 | 1 payment
|
2021: $65
| HeartFlow | Ffrct | $33 | 2 payments
|
| Abbott Laboratories | Mitraclip System | $32 | 1 payment
|
2019: $22
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $22 | 1 payment
|
Professional record
- NPI
- 1336150234
- Licence
- CA A87538California A87538: Current · expires 2028-06-30
- Group
- Stanford Health Care · Sutter Bay Medical Foundation
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Cardiology (207RC0000X); Federal specialty code 207UN0901X (207UN0901X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2006-08-10
- NPI last updated
- 2024-04-24
- NPI record certified
- 2024-04-24
This is when the NPI record was last certified, not a medical board exam.